Skip to main content
. 2022 Apr 20;23:143. doi: 10.1186/s12859-022-04662-6

Table 21.

Top 10 pairs of drugs with their correlation with subtype 9 of breast cancer, considering both combined and individually

Drug1 Drug2 C. Cor. Cor. 1 Cor. 2 C. Rank Rank 1 Rank 2
Rupatadine TG-100801 − 0.85 − 0.72 − 0.61 1 1 8
L-690330 Favipiravir − 0.83 − 0.65 − 0.48 2 5 76
Rupatadine Lidocaine − 0.82 − 0.72 − 0.51 3 1 51
Rupatadine MG-132 − 0.82 − 0.72 − 0.61 4 1 9
Rupatadine ICI-185,282 − 0.81 − 0.72 − 0.52 5 1 35
Rupatadine Telatinib − 0.79 − 0.72 − 0.47 6 1 82
Rupatadine Vidarabine − 0.79 − 0.72 − 0.59 7 1 12
Garcinol CL-218872 − 0.78 − 0.56 − 0.49 8 24 60
Rupatadine Bitopertin − 0.77 − 0.72 − 0.48 9 1 71
Emtricitabine Bitopertin − 0.77 − 0.65 − 0.48 10 4 71